ADELAIDE medical technology company LBT Innovations will welcome new investors through an $8 million share placement.
The company, which makes artificial intelligence-based automated systems for laboratories, will use the funds to support sales activities in Europe and the US. LBT issued 50 million new shares at 16c to raise the funds.
A share purchase plan to raise another $1 million from existing shareholders at same per-share price has also been announced. Earlier this week, LBT chief executive Brent Barnes described a new three-year marketing partnership with Beckman Coulter for the EU market as a “significant step forward” in the commercialisation of its APAS Independence systems. Shares in LBT closed more than 2.5 per cent lower at 18.5c yesterday.
Word count: 119
